Home > Insider Trading > Filing (0001610717-23-000261)

Filing Details

Accession Number:: 0001610717-23-000261
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-09-06 20:05:26
Reporting Period:: 2023-09-01

Accepted Time:: 2023-09-06 20:05:26
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1628171	Revolution Medicines Inc.	RVMD	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1246842	A Mark Goldsmith	C/O Revolution Medicines, Inc. 700 Saginaw Drive Redwood City CA 94063	See Remarks	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-09-01	17,993	$0.54	375,379	No	4	M	Direct
Common Stock	Acquisiton	2023-09-01	12,007	$1.12	387,386	No	4	M	Direct
Common Stock	Disposition	2023-09-01	30,000	$35.05	357,386	No	4	S	Direct
Common Stock	Disposition	2023-09-01	5,000	$35.04	35,424	No	4	S	Indirect	Trust
Common Stock	Disposition	2023-09-01	5,000	$35.04	35,424	No	4	S	Indirect	Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Indirect	Trust
No	4	S	Indirect	Trust

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2023-09-01	17,993	$0.00	17,993	$0.54
Common Stock	Stock Option (Right to Buy)	Disposition	2023-09-01	12,007	$0.00	12,007	$1.12

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
205,503	2022-03-01	2028-02-11	No	4	M	Direct
46,479	2022-03-29	2028-04-19	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	327,547	Indirect	Trust

Footnotes

Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on November 22, 2022.
Includes 190,000 restricted stock units.
Includes 1,514 shares acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2023.
This transaction was executed in multiple trades at prices ranging from $35.00 to $35.24. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Transaction made pursuant to a 10b5-1 trading plan adopted by the Jonathan Henry Goldsmith Trust on November 21, 2022.
This transaction was executed in multiple trades at prices ranging from $35.00 to $35.16. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Held by Jonathan Henry Goldsmith Trust under the Goldsmith Children's 2011 Irrevocable Education Trust, dated December 15, 2011.
Transaction made pursuant to a 10b5-1 trading plan adopted by the Rebecca Eve Goldsmith Trust on November 21, 2022.
This transaction was executed in multiple trades at prices ranging from $35.00 to $35.22. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Held by Rebecca Eve Goldsmith Trust under the Goldsmith Children's 2011 Irrevocable Education Trust, dated December 15, 2011.
Held by Mark A. Goldsmith and Anne E. Midler 2002 Revocable Living Trust.